Stopped: Study was discontinued in 2018 as sufficient sample size was not met.
Study of patients with nonvalvular atrial fibrillation (NVAF) who are newly prescribed NOACs (Novel Oral Anticoagulants) in routine clinical practice in England
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of major bleeding
Timeframe: At the end of 1 year
Incidence of intracranial bleeding
Timeframe: At the end of 1 year
Incidence of gastrointestinal bleeding
Timeframe: At the end of 1 year
Incidence of clinically relevant non-major bleeding
Timeframe: At the end of 1 year
Incidence of ischemic stroke
Timeframe: At the end of 1 year
Incidence of unspecified stroke
Timeframe: At the end of 1 year
Incidence of systemic embolic events
Timeframe: At the end of 1 year